rethinkPeptides Search
Menu
Research citation

Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.

The lancet. Diabetes & endocrinology, 13(1), 15-28

Citation

Badve, Sunil V; Bilal, Anika; Lee, Matthew M Y; Sattar, Naveed; Gerstein, Hertzel C; Ruff, Christian T; McMurray, John J V; Rossing, Peter; Bakris, George; Mahaffey, Kenneth W; Mann, Johannes F E; Colhoun, Helen M; Tuttle, Katherine R; Pratley, Richard E; Perkovic, Vlado. (2025). Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.. The lancet. Diabetes & endocrinology, 13(1), 15-28. https://doi.org/10.1016/S2213-8587(24)00271-7